Nursing Dilemmas in Chemotherapy-Induced Peripheral Neuropathy: A Qualitative Study of a Tertiary Hospital in China

Overview

Journal J Pain Res

Publisher Dove Medical Press

Date 2023 Jul 12

PMID 37435154

Authors

Jia Xin Fan

Ya Chen Hu

Xinxin Chen

Yumei Li

Affiliations

Soon will be listed here.

Abstract

Purpose: This study investigated the experience of oncology nurses caring for chemotherapy-induced peripheral neuritis patients.

Patients And Methods: Through phenomenological research method, 11 nurses in a tertiary hospital in Shanghai were interviewed using face-to-face semi-structured interviews. Data analysis was conducted with the thematic analysis approach.

Results: This analysis revealed the experiences of oncology nurses in caring for patients with CIPN and identified three themes: 1) stress in the nursing of CIPN (inadequate knowledge of CIPN among oncology nurses, oncology nurses' CIPN nursing skills need to be improved, negative emotions of oncology nurses at work); 2) environmental dilemmas in nursing of CIPN (lack of effective care norms, busy schedules, doctors pay little attention to CIPN); 3) oncology nurses' desire to improve their knowledge of CIPN to meet care needs.

Conclusion: Based on the perspective of oncology nurses, the care dilemma of CIPN is mainly influenced by individual and environmental factors. It is recommended to enhance the attention of oncology nurses to CIPN, set specific and feasible training courses, explore CIPN assessment tools that meet our clinical practice, and construct CIPN care programs to improve CIPN clinical care ability and reduce patient suffering.

Citing Articles

Peripheral Neuropathy Instruments for Individuals with Cancer: A COSMIN-Based Systematic Review of Measurement Properties.

Belloni S, Magon A, Giacon C, Savioni F, Conte G, Caruso R Curr Oncol. 2024; 31(12):7828-7851.

PMID: 39727700 PMC: 11674663. DOI: 10.3390/curroncol31120577.

Exploring Chemotherapy-Induced Peripheral Neuropathy Management Practice Patterns Among Oncology Clinicians.

Kanzawa-Lee G, Krauss J, Knoerl R Semin Oncol Nurs. 2024; 40(5):151685.

PMID: 38937199 PMC: 11665820. DOI: 10.1016/j.soncn.2024.151685.

References

Jahn F, Wormann B, Brandt J, Freidank A, Feyer P, Jordan K . The Prevention and Treatment of Nausea and Vomiting During Tumor Therapy. Dtsch Arztebl Int. 2022; 119(21):382-392. PMC: 9487713. DOI: 10.3238/arztebl.m2022.0093. View

Jia M, Wu C, Gao F, Xiang H, Sun N, Peng P . Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain. Mol Pain. 2017; 13:1744806917719804. PMC: 5562344. DOI: 10.1177/1744806917719804. View

Paus R, Haslam I, Sharov A, Botchkarev V . Pathobiology of chemotherapy-induced hair loss. Lancet Oncol. 2013; 14(2):e50-9. DOI: 10.1016/S1470-2045(12)70553-3. View

Conley C, Kamen C, Heckler C, Janelsins M, Morrow G, Peppone L . Modafinil Moderates the Relationship Between Cancer-Related Fatigue and Depression in 541 Patients Receiving Chemotherapy. J Clin Psychopharmacol. 2015; 36(1):82-5. PMC: 4689625. DOI: 10.1097/JCP.0000000000000442. View

Jordan B, Margulies A, Cardoso F, Cavaletti G, Haugnes H, Jahn P . Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020; 31(10):1306-1319. DOI: 10.1016/j.annonc.2020.07.003. View

Colvin L . Chemotherapy-induced peripheral neuropathy: where are we now?. Pain. 2019; 160 Suppl 1:S1-S10. PMC: 6499732. DOI: 10.1097/j.pain.0000000000001540. View

Kanzawa-Lee G . Chemotherapy-Induced Peripheral Neuropathy: Nursing Implications. J Infus Nurs. 2020; 43(3):155-166. DOI: 10.1097/NAN.0000000000000368. View

Morrison E, Novotny P, Sloan J, Yang P, Patten C, Ruddy K . Emotional Problems, Quality of Life, and Symptom Burden in Patients With Lung Cancer. Clin Lung Cancer. 2017; 18(5):497-503. PMC: 9062944. DOI: 10.1016/j.cllc.2017.02.008. View

Miaskowski C, Mastick J, Paul S, Abrams G, Cheung S, Sabes J . Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life. J Cancer Surviv. 2017; 12(2):234-245. PMC: 5886787. DOI: 10.1007/s11764-017-0662-8. View

10.

Banach M, Juranek J, Zygulska A . Chemotherapy-induced neuropathies-a growing problem for patients and health care providers. Brain Behav. 2017; 7(1):e00558. PMC: 5256170. DOI: 10.1002/brb3.558. View

11.

Dong Z, Wang Y, Cheng M, Wang B, Lu H, Zhu H . 2-Bromopalmitate decreases spinal inflammation and attenuates oxaliplatin-induced neuropathic pain via reducing Drp1-mediated mitochondrial dysfunction. PLoS One. 2022; 17(10):e0275428. PMC: 9621438. DOI: 10.1371/journal.pone.0275428. View

12.

Flatters S, Dougherty P, Colvin L . Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review. Br J Anaesth. 2017; 119(4):737-749. DOI: 10.1093/bja/aex229. View

13.

Kleckner I, Kamen C, Gewandter J, Mohile N, Heckler C, Culakova E . Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer. 2017; 26(4):1019-1028. PMC: 5823751. DOI: 10.1007/s00520-017-4013-0. View

14.

Jones S, Erban J, Overmoyer B, Budd G, Hutchins L, Lower E . Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol. 2005; 23(24):5542-51. DOI: 10.1200/JCO.2005.02.027. View

15.

Bhatnagar B, Gilmore S, Goloubeva O, Pelser C, Medeiros M, Chumsri S . Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience. Springerplus. 2014; 3:366. PMC: 4117856. DOI: 10.1186/2193-1801-3-366. View

16.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

17.

Avallone A, Bimonte S, Cardone C, Cascella M, Cuomo A . Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy. Anticancer Res. 2022; 42(10):4667-4678. DOI: 10.21873/anticanres.15971. View

18.

Connolly M, Perryman J, McKenna Y, Orford J, Thomson L, Shuttleworth J . SAGE & THYME: a model for training health and social care professionals in patient-focussed support. Patient Educ Couns. 2009; 79(1):87-93. DOI: 10.1016/j.pec.2009.06.004. View

19.

Alejandro L, Behrendt C, Chen K, Openshaw H, Shibata S . Predicting acute and persistent neuropathy associated with oxaliplatin. Am J Clin Oncol. 2012; 36(4):331-7. PMC: 4080710. DOI: 10.1097/COC.0b013e318246b50d. View

20.

Epstein R, Aapro M, Basu Roy U, Salimi T, Krenitsky J, Leone-Perkins M . Patient Burden and Real-World Management of Chemotherapy-Induced Myelosuppression: Results from an Online Survey of Patients with Solid Tumors. Adv Ther. 2020; 37(8):3606-3618. PMC: 7340862. DOI: 10.1007/s12325-020-01419-6. View